Currently viewing the category: "Sanofi-Aventis"

Big Pharma making big cuts in R&D

By · 1 Comment

According to reports, the axe is coming down all over the pharma world on research and development projects that are not yielding immediate results.

AstraZeneca(Atacand, Crestor), GlaxoSmithKline (Advair, Boniva) and Pfizer (Benadryl, Lipitor) have all already begun to scrap projects, while others like Sanofi-Aventis (Allegra, Plavix) [...]

Continue Reading →

The Fosamax mistrial, and other options in osteoporosis medication

By · 1 Comment

Earlier this month, a closely-watched trial over the osteoporosis drug Fosamax ended in mistrial, to the frustration of nearly everyone involved. The trial was marked by great tension, with a deadlocked jury, reports of threats of physical violence, and a judge-ordered cooling-down period.

What could [...]

Continue Reading →

Zimulti: An obesity drug to die for?

By · Leave a Comment

From Bloomberg:

Sanofi-Aventis SA shares had their biggest drop in three years, wiping out more than $7 billion in market value, after a U.S. panel blocked the company’s new weight-loss pill because it was linked to suicides.

Says Derek Lowe:

Everyone will have heard the news about Wednesday’s FDA Advisory [...]

Continue Reading →

Generic Ambien on the way

By · 1 Comment

In case you were sleeping when the news was announced last week, generic versions of Ambien are on the way. As Reuters reported:

The Food and Drug Administration said … that regulators had approved generic versions of Ambien, a blockbuster sleeping pill from Sanofi-Aventis. The drug, also known as zolpidem tartrate, has been [...]

Continue Reading →

New “black box” warning on controversial antibiotic

By · Leave a Comment

The FDA announced that the antibiotic Ketek, used to treat pneumonia, must come with a new “black box label” — the strongest warning the agency can impose on a drug. Additionally, Ketek can no longer be recommended for treating milder conditions such as sinusitis and bronchitis. The changes come after the medication was [...]

Continue Reading →